Simulations Plus (NASDAQ:SLP – Get Free Report) announced its quarterly earnings results on Wednesday. The technology company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.02, Briefing.com reports. Simulations Plus had a net margin of 16.22% and a return on equity of 8.02%. The firm had revenue of $18.31 million during the quarter, compared to the consensus estimate of $17.31 million. During the same period last year, the firm posted $0.20 EPS. The firm’s quarterly revenue was up 16.2% on a year-over-year basis. Simulations Plus updated its FY24 guidance to $0.66-0.68 EPS and its FY 2024 guidance to 0.660-0.680 EPS.
Simulations Plus Price Performance
SLP traded down $0.03 during trading on Friday, reaching $47.51. The company had a trading volume of 65,849 shares, compared to its average volume of 108,038. Simulations Plus has a 12 month low of $32.69 and a 12 month high of $52.69. The business’s fifty day moving average price is $41.48 and its 200 day moving average price is $40.43. The company has a market cap of $948.77 million, a P/E ratio of 89.70 and a beta of 0.72.
Simulations Plus Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, May 6th. Shareholders of record on Monday, April 29th will be paid a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 0.51%. The ex-dividend date is Friday, April 26th. Simulations Plus’s payout ratio is currently 45.28%.
Insider Transactions at Simulations Plus
Hedge Funds Weigh In On Simulations Plus
Institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of Simulations Plus by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 1,122,469 shares of the technology company’s stock valued at $50,230,000 after acquiring an additional 3,591 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Simulations Plus by 17.3% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 9,486 shares of the technology company’s stock valued at $425,000 after acquiring an additional 1,397 shares in the last quarter. Barclays PLC grew its stake in shares of Simulations Plus by 20,036.3% in the fourth quarter. Barclays PLC now owns 24,969 shares of the technology company’s stock valued at $1,118,000 after acquiring an additional 24,845 shares in the last quarter. Nuveen Asset Management LLC grew its stake in shares of Simulations Plus by 1.3% in the fourth quarter. Nuveen Asset Management LLC now owns 47,067 shares of the technology company’s stock valued at $2,106,000 after acquiring an additional 585 shares in the last quarter. Finally, Public Sector Pension Investment Board grew its stake in shares of Simulations Plus by 68.0% in the fourth quarter. Public Sector Pension Investment Board now owns 33,105 shares of the technology company’s stock valued at $1,481,000 after acquiring an additional 13,402 shares in the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Separately, Craig Hallum raised their price objective on shares of Simulations Plus from $50.00 to $51.00 and gave the company a “buy” rating in a research report on Thursday, January 4th.
Get Our Latest Stock Report on Simulations Plus
Simulations Plus Company Profile
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Further Reading
- Five stocks we like better than Simulations Plus
- Golden Cross Stocks: Pattern, Examples and Charts
- 5 Stocks in the Current Bull Market with Upside to Come
- Stock Dividend Cuts Happen Are You Ready?
- 5 High Short Interest Stocks Getting Squeezed With Upside To Go
- What Are Dividend Challengers?
- Intel’s Foundry Woes: Sell Signal or Silver Lining Ahead?
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.